MindWalk Holdings (HYFT) Other Operating Expenses (2020 - 2026)
MindWalk Holdings (HYFT) reported Other Operating Expenses of $1.3 million for Q1 2026, down 91.94% year-over-year from $16.1 million in Q1 2025, and up 141.91% quarter-over-quarter from -$3.1 million in Q4 2025.
MindWalk Holdings (HYFT) Other Operating Expenses (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Other Operating Expenses data on file, last reported at $1.3 million in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $1.3 million, down 91.94% year-over-year; the trailing twelve-month figure through Jan 2026 was -$1.8 million (down 100.23% YoY), and the FY2025 annual result was -$507546.3, down 263.46% from the prior year.
- Other Operating Expenses advanced to $1.3 million in Q1 2026 per HYFT's latest filing, from -$3.1 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $1.4 billion in Q3 2023 and troughed at -$12.2 million in Q2 2022.
- A 5-year average of $131.2 million and a median of $1.3 million in 2022 frame the typical range for Other Operating Expenses.
- On a YoY basis, Other Operating Expenses climbed as much as 40494.5% in 2022 and fell as far as 419.77% in 2022.
- A 5-year view of Other Operating Expenses shows it stood at $1.3 million in 2022, then decreased by 9.68% to $1.2 million in 2023, then decreased by 4.9% to $1.1 million in 2024, then slumped by 370.42% to -$3.1 million in 2025, then soared by 141.91% to $1.3 million in 2026.
- Business Quant data shows HYFT's Other Operating Expenses at $1.3 million in Q1 2026, -$3.1 million in Q4 2025, and $757.62 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 1.30 Mn |
| Oct 31, 2025 | -3.10 Mn |
| Jul 31, 2025 | 757.62 |
| Apr 30, 2025 | 11,694.81 |
| Jan 31, 2025 | 16.09 Mn |
| Oct 31, 2024 | 1.14 Mn |
| Jul 31, 2024 | 760.25 Mn |
| Apr 30, 2024 | 12.27 Mn |
| Jan 31, 2024 | 1.00 Mn |
| Oct 31, 2023 | 1.20 Mn |
| Jul 31, 2023 | 1.43 Bn |
| Apr 30, 2023 | 3.59 Mn |
| Jan 31, 2023 | 1.39 Mn |
| Oct 31, 2022 | 1.33 Mn |
| Jul 31, 2022 | 9.75 Mn |
| Apr 30, 2022 | -12.18 Mn |
| Jan 31, 2022 | 5.44 Mn |
| Oct 31, 2021 | 3,282.77 |
| Jul 31, 2021 | 3.70 Mn |
| Apr 30, 2021 | 3.81 Mn |